WallStreetZenWallStreetZen

NASDAQ: CGTX
Cognition Therapeutics Inc Stock Ownership - Who owns Cognition Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cognition Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John Brendan DoyleChief Financial Officer2024-05-018,699$1.95
$16.96kSell
Lisa RicciardiCEO President2024-03-145,700$1.75
$9.98kBuy
Anthony CaggianoChief Medical Officer2024-02-0312,777$2.29
$29.26kSell
Lisa RicciardiCEO President2024-02-0327,828$2.29
$63.73kSell

1 of 1

CGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CGTX insiders and whales buy or sell their stock.

CGTX Shareholders

What type of owners hold Cognition Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aaron Gl Fletcher24.63%10,235,218$4.43MInsider
Leslie W. Kreis15.22%6,322,377$2.74MInsider
Bios Memory Spv I LP9.42%3,912,841$1.69MInsider
Ogden Cap Associates LLC5.32%2,210,377$957.09kInsider
Vanguard Group Inc2.99%1,242,554$538.03kInstitution
Bios Clinical Opportunity Fund LP1.20%500,095$216.54kInsider
Alyeska Investment Group LP1.20%500,000$216.50kInstitution
Mark H. Breedlove0.99%412,050$178.42kInsider
Geode Capital Management LLC0.78%323,643$140.14kInstitution
Lisa Ricciardi0.70%291,345$126.15kInsider

1 of 3

CGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CGTX10.24%58.39%Net Selling
MTVA3.81%96.19%Net BuyingNet Selling
TENX8.53%91.47%
NNVC2.50%97.50%
CVKD0.00%100.00%
View Top Biotech Stocks

Cognition Therapeutics Stock Ownership FAQ

Who owns Cognition Therapeutics?

Cognition Therapeutics (NASDAQ: CGTX) is owned by 10.24% institutional shareholders, 58.39% Cognition Therapeutics insiders, and 31.38% retail investors. Aaron Gl Fletcher is the largest individual Cognition Therapeutics shareholder, owning 10.24M shares representing 24.63% of the company. Aaron Gl Fletcher's Cognition Therapeutics shares are currently valued at $4.97M.

If you're new to stock investing, here's how to buy Cognition Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.